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ABSTRACT: 
 
We report here on four cases of patients with strongly positive anti citrullinated cyclic 
peptides (anti-CCP) antibodies and clinical features of seronegative spondyloarthritis (SpA) 
and reactive arthritis. The four patients had various clinical presentations: one had an initial 
diagnosis of seropositive rheumatoid arthritis (RA) with involvement of the sacroiliac joints 
(similar to previous reports of the association of two diseases); one had a clinical picture of 
reactive arthritis following an episode of an E. Coli positive urinary tract infection; and two 
had asymmetrical sacroiliitis (SII), but no evidence of peripheral joint involvement (never 
reported before). In all cases, high titres of anti CCP antibodies were found. We present a 
comparison of the clinical manifestations, radiographic features and treatment regimens of 
these cases. Our report supports previous literature data of possible overlap existing between 
RA and SpA, but also presents for the first time the association of high titres of anti-CCP 
antibodies with SII and reactive arthritis in patients with no peripheral small joint 
involvement.  
 
 
INTRODUCTION 
 
RA is a chronic autoimmune, inflammatory condition, characterised by a symmetrical 
deforming polyarthritis with a higher prevalence amongst women (1). Involvement of the 
axial skeleton is rare except for the cervical spine (2).  The diagnosis of RA is made based on 
the revised 2010 ACR/EULAR classification criteria, which combine clinical and laboratory 
parameters (3). RA is associated with the presence of rheumatoid factor (RF) in approximately 
70% of patients and anti-CCP antibody in 60-70% (4, 5). The presence of anti-CCP antibodies 
is highly specific (around 90%) for RA (6, 7). RA is a multifactorial disease influenced by various 
genetic, family and lifestyle factors (7, 8). Smoking is one documented association, with 
smokers having a higher incidence of RF positive disease when compared to non-smokers (9).  
 
In contrast, the spondyloarthropathies (SpAs) are a constellation of inflammatory arthritic 
conditions characterised by the absence of rheumatoid factor and anti-CCP, hence the 
distinction of the group as ‘seronegative’ arthritides (10).  In addition, their main clinical 
feature is an inflammatory arthritis of the axial skeleton which commonly manifests as 
inflammatory back pain typically affecting younger patients (<45 years old).  In particular, 
involvement of the sacroiliac joint (SIJ), defined as SII, is the hallmark of the disease, being 
considered the most common manifestation and initial site of joint involvement. Like RA, SpA 
is diagnosed based on well-defined criteria, including clinical and imaging modalities, such as 
X-ray and magnetic resonance imaging (MRI) (11, 12).     
 
Reactive arthritis or “sterile inflammatory arthritis” typically presents as an acute 
oligoarticular arthritis of the larger joints of the lower limb. Importantly it is preceded by an 
episode of urethritis or dysentery 1-4 weeks before the onset of symptoms (13). Diagnosis of 
reactive arthritis is also made clinically, but with a clear history of previous infection within 
the last month. Reactive arthritis may be distinguished from the most common SpA, 
ankylosing spondylitis (AS), by the pattern of the SII and increased frequency of peripheral 
joint involvement (14). Whereas the inflammation of SIJ is frequently symmetrical in AS, it 
tends to be more asymmetric in reactive arthritis. In all of these arthritides, inflammatory 
markers such as CRP and ESR can be raised, but it is increasingly recognised that in some cases 
the joint inflammation is not reflected by a systemic inflammatory response (15). Extra-
articular signs, particularly inflammatory eye symptoms can be present in many patients (16). 
 
We report here four cases of patients who presented to our Rheumatology department with 
high titres of anti-CCP and RF but with symptoms that fit a clinical diagnosis of a SpA, including 
reactive arthritis. We present a comparison of their clinical manifestations and radiographic 
features, markers of inflammation, as well as treatment regimens. We also reviewed the 
literature regarding similar case-reports and previous evidence of presence of positive anti 
CCP antibodies in patients with SpA.  
 
 PATIENTS AND METHODS 
 
Case Report 1 
 
A 46-year-old female patient was diagnosed with seropositive RA in 2011 (anti-CCP 
antibodies, RF antibodies and antinuclear antibodies positive).  The patient was treated with 
methotrexate from the time of her diagnosis (which was close to the onset of her symptoms), 
and was on a stable dose of 15mg subcutaneously (SC), once weekly, and additional 
intermittent treatment with naproxen.   
 
This patient was referred to our clinic seeking a second opinion with regard to previous 
radiographic evidence of bilateral SII (on repeated assessments in 2012 and 2015).  At the 
time of the referral, the patient complained of inflammatory low back pain, mainly affecting 
the lumbosacral area, radiating down to her buttocks, and occasional hip pain. The pain was 
associated with early morning stiffness and was present at night as well.  On further 
questioning, the patient described dry eyes with possible episodes of eye redness in the past 
but had never received a diagnosis of iritis or keratitis.  She denied significant changes in her 
bowel habit and stool appearance and had never had a diagnosis of inflammatory bowel 
disease.   
 
On examination, there was no evidence of tender or swollen peripheral joints, enthesitis or 
dactylitis, but she described intermittent pain (arthralgia) in her fingers and had localised SII 
joint pain with well-preserved mobility within her spine. The patient had no history of 
hypermobility or pelvic trauma. She was tested HLA-B27 positive. 
 
In order to appreciate if her inflammatory sounding low back pain was associated with on-
going inflammation of her SIJs, we performed an MRI scan of her lumbar spine and SIJs. The 
MRI report described erosions of the SIJ margins bilaterally and marked bone marrow oedema 
of the sacral margin of the right SIJ, in keeping with a combination of active and chronic SII 
(Figure 1) and no evidence of spinal inflammation. In addition, we performed an ultrasound 
examination of her hands, which revealed chronic erosions and synovial hypertrophy, without 
Doppler signal, suggesting well-controlled, erosive RA.  The patient was treated with two 
different courses of NSAIDs for a duration of 4 weeks, but experienced no significant clinical 
improvement, and was initiated on biologic treatment with anti-TNF blockade afterwards.  
 
Case Report 2  
 
A 54-year-old Bangladeshi woman was admitted to our inpatient service with a 2-week history 
of fever and progressive right-sided hip pain, with significant difficulty mobilising herself.  She 
denied lower back or buttock pain and any other arthralgia.  Additionally, there was no 
evidence of other infective symptoms, apart from dysuria.  She travelled recently to 
Bangladesh for 3 weeks, but denied any history of tuberculosis (TB) or recent TB contact.  Her 
past medical history was significant for hypertension, hyperthyroidism, vitamin D deficiency, 
pituitary microprolactinoma. She was also a smoker (10 pack/year) and had no personal or 
family history or inflammatory arthritis.  
 
On examination, the right hip had good range of movement with tenderness on external 
rotation and over the lateral aspect of her thigh. The joint itself was neither hot nor tender 
and there was no evidence of skin infective changes or enlarged inguinal lymph nodes. Her 
neurological examination was unremarkable.  On her blood results, inflammatory markers 
were elevated; CRP was > 100 mg/l, the anti CCP antibodies and RF were strongly positive, 
and all the other blood tests were normal.  The urinalysis showed urinary infection with E.Coli 
which was treated with Nitrofurantoin. Pelvic X-rays showed mild degenerative changes in 
both hips.    
 
MRI demonstrated a moderate right hip joint effusion, hip synovitis and periarticular soft 
tissue inflammation (Figure 2).  Furthermore, the scan revealed some mild sclerosis and 
irregularity at the anterior inferior margin of the right sacroiliac joint, without signs of active 
SII.  The patient was treated with intramuscular steroid injection in addition to analgesia 
(NSAIDs and paracetamol) and her symptoms improved significantly after 5 days.  She was 
discharged for follow up in the outpatient clinics.  From a functional perspective, the patient 
has continued to improve her mobility and the hip pain subsided.  Her follow-up blood tests 
showed resolution of the systemic inflammatory response and normal urinalysis. In light of 
both a clinical and biochemical improvement, the clinical appreciation was that the patient 
developed acute hip arthritis secondary to urinary infection with E Coli with complete clinical 
resolution of symptoms.  
 
Case Report 3  
 
A 56-year-old female patient was referred to our in-patient service for longstanding history 
of lower back pain. In October 2009 she had been operated on for a slipped disc at L4-L5 level 
and following surgical intervention, the patient had been symptom-free for approximately 
two years. Since 2011 her pain had returned and changed pattern, as she experienced left 
thigh radiation of her low back pain associated with early morning stiffness lasting 
approximately one hour, which improved with activity.  She was treated with diclofenac 
followed by naproxen, but was unable to tolerate any of the anti-inflammatories because of 
associated abdominal discomfort.  She received a previous diagnosis of RA of the SIJ based on 
repeated MRI scans, which demonstrated evidence of right SII in association to strongly 
positive anti CCP antibodies (in association with L4-L5 disc degenerative changes without 
nerve compression).  
 
Her history was significant for an episode of acute iritis, bruxism and type 2 diabetes mellitus, 
but no history of hypermobility or arthritis.  The patient was a previous smoker but quit 8 
years ago.  The patient had no symptoms of psoriasis or inflammatory bowel disease and was 
peri-menopausal. 
 
On examination, there was restricted mobility in anterior flexion of the lumbar spine with a 
fingers-to-floor index of 20cm and a restricted lateral flexion. Schober’s manoeuvre found 4 
cm expansion of the lumbar spine with anterior flexion. She had low back pain with right SIJ 
pain on palpation, pain over the trochanteric area, but no evidence of peripheral arthralgia, 
synovitis or dactylitis.  The rest of her clinical examination was within normal limits. A 
repeated MRI organised after clinical review showed pronounced left SII (Figure 3). Based on 
spinal pain severity and BASDAI score, associated with poor response to NSAIDs, the patient 
was initiated on treatment with anti TNF agents, and improved clinically when evaluated after 
6 months. 
 
Case report 4 
 
A 23-year-old female patient was referred to the rheumatology outpatient clinics for 
symptoms of inflammatory sounding hand and low back pain. There was no relevant personal 
or family medical history. Extensive investigations showed strongly positive anti CCP 
antibodies, positive HLA-B27, increased inflammatory markers, normal radiographs of hands 
and feet, and sclerosis of the left SIJ and joint space narrowing affecting both the hip and SIJ 
on the left hand-side on pelvis Xrays (Figure 4). Further MRI imaging found active left SII and 
left hip synovitis, and the US examination of hands and feet was normal. The patient was 
started on a trial of two different NSAIDs and a guided steroid injection for her hip was 
organised. A follow-up to review progression of her symptoms was organised, with regard to 
escalating her therapy in the case of unsatisfactory response to NSAIDs.  
 
We detailed below the clinical, laboratory and imaging features of the case reports (Table 1).  
 
 
DISCUSSION 
 
Seronegative arthritis is defined by the absence of RF and anti CCP antibodies, characteristic 
SIJ and peripheral joint involvement and associated pathology (such as psoriasis, 
inflammatory eye and bowel disease). While there are similarities among the clinical entities 
included in this group of SpAs, there are also specific characteristics of each of these 
conditions that help distinguish them. The diagnosis of different types of inflammatory 
arthritis is facilitated by imaging, with ultrasound examination being the most commonly used 
imaging modality for assessing active inflammatory changes in RA (17), while MRI imaging is 
included in the classification criteria for SpAs (18). 
 The presence of anti CCP is of particular importance in RA due to its high specificity and its 
use as a prognostic factor for joint erosion and disease progression (19). A large study 
reported a prevalence of 4% of anti CCP positive in AS patients with peripheral joint 
involvement and associated female predominance (20); although, the novelty of the cases 
presented here is that the antibodies were found in patients with exclusive axial involvement. 
Anti CCP antibodies were also present in other rheumatic conditions, being found in 10.6% of 
patients with psoriatic arthritis, 20.9% of patients with unclassified rheumatism in another 
study (21). There are also case-reports of concomitant diagnosis of seropositive RA and 
bilateral SII in some patients (22, 23), and the authors suggested that the prevalence of SpA 
features in patients with RA may be much higher than previously recognised.  
 
The citrullination process is well recognised as associated with the tuberculosis infection, and 
cases of Poncet’s disease with peripheral involvement and positive anti CCP antibodies have 
also been reported (24); however, there are no previous reports of reactive arthritis without 
peripheral joint involvement secondary to other bacterial infections than tuberculosis as the 
one we present here. The particularity of our case is that the clinical presentation of reactive 
arthritis without features of RA was associated with strongly positive anti CCP antibodies, 
which is different from previous reports of co-existence of RA and reactive arthritis (25, 26).  
 
The four patients in this report had various clinical presentations; while only one had an initial 
diagnosis of seropositive RA with concomitant involvement of the SIJ found later on imaging, 
suggesting a co-existence of two different diseases. The other three patients, one with 
symptoms of mono-arthritis in the context of recent urinary infection, and two with 
inflammatory asymmetric SII had no clinical or imaging evidence of peripheral polyarthritis, 
which was identified as more commonly associated with the presence of anti CCP antibodies 
in patients with SpA (20). All four patients had high titres of anti-CCP antibodies and were 
females, and two out of four were smokers or ex-smokers. None of the patients had family 
history of RA. Only two patients were HLA-B27 positive and both had MRI evidence of active 
SII.  
 
This mini case-series raised clinician awareness about the possibility of the association of 
clinical features typical for SpA and high titre of anti CCP antibodies in the absence of 
peripheral arthritis, which has not been reported before. A further follow up of these patients 
is required to assess if they are at risk of developing overt clinical features of both diseases 
(RA and SpA), and to establish optimal therapeutic options needed to ensure long term 
disease control.  
 
 
 
 
 
Table 1: Summary of the case-reports’ characteristics. 
 Case 1 Case 2 Case 3 Case 4 
Sex/Age F/46 F/54 F /56 F/23 
Clinical 
features of 
RA 
Yes No No No 
Smoking 
status 
Ex-smoker Smoker Non-smoker Non-smoker 
RF Yes Yes Yes Yes 
CCP (>3 times 
upper limit) 
Yes Yes Yes Yes 
US of small 
joints for 
assessment 
of RA activity 
Evidence of 
erosions and 
well-controlled 
disease 
N/A Normal Normal 
Presence of 
active SII on 
MRI 
Yes / bilateral No Yes / unilateral Yes / unilateral 
Hip synovitis 
on MRI 
No Yes No Yes 
HLA B 27 Positive Negative Negative Positive 
Clinical 
picture of 
ReA 
No Yes No No 
Infection 
preceding 
the onset of 
arthritis 
No UTI with E Coli 
(2 weeks prior 
to arthritis 
onset) 
No No 
Bowel  
inflammatory  
symptoms 
No No No No 
Eye 
inflammatory 
symptoms 
Possible 
keratitis in the 
past 
No Uveitis in the 
past 
No 
Psoriasis No No No No 
Treatment MTX 
 
NSAIDs 
 
Anti TNF 
therapy 
Steroids 
 
NSAIDs 
NSAIDs 
 
Physiotherapy 
 
Acupuncture 
 
Anti TNF therapy 
NSAIDs 
 
Physiotherapy 
 
 
 
 
 
 
 
 
  
 
Figure 1: Bilateral SII (joint space narrowing and sclerosis on pelvic Xray and bone marrow 
oedema on MRI) in a patient with symmetrical polyarthralgia, in the context of previous 
diagnosis of RA associated with strongly positive anti CCP antibodies. 
 
 
 
 
 
Figure 2: Right hip effusion and synovitis in a patient with clinical picture of reactive arthritis 
and strongly positive anti CCP antibodies, following urinary infection with E. Coli (post-
contrast MRI). 
 
 
 
 
 
Figure 3: Left SII in a patient with strongly positive CCP antibodies and inflammatory spinal 
pains (pseudo widening of the joint space and bone irregularities of the left SIJ on 
conventional radiograph and bone marrow oedema affecting both sides of the joint on post-
contrast MRI). 
  
 
 
 
 
Figure 4: Left hip arthritis with significant joint space narrowing and left SII associated with 
bone sclerosis on conventional radiograph, and massive synovitis on MRI (post-contrast) in a 
patient with strongly positive anti CCP antibodies. 
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